Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Gilead wins reversal of $2.54 bln hepatitis C drug patent verdict

Editor's pick
Nasdaq
19 February 2018
New & experimental HIV treatments

ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment

Editor's pick
ViiV press release
8 February 2018
New & experimental HIV treatments

US FDA approves Gilead triple HIV drug, rival files lawsuit

Editor's pick
Reuters
8 February 2018
Pharmaceutical industry

Janssen HIV Drug U.K. Patent Extension Case to Go to EU Top Court

Editor's pick
Bloomberg
7 February 2018
PEP

Activists Demand Gilead Rescind nPEP Patient Access Program's Once-Per-Lifetime Use Limit

Editor's pick
The Body
2 February 2018
Pharmaceutical industry

GlaxoSmithKline Projects Tough Environment for Triumeq and Tivicay

Editor's pick
Market Realist
1 February 2018
Pharmaceutical industry

Brexit could leave patients unable to access new drugs

Editor's pick
The Guardian
30 January 2018
Pharmaceutical industry

Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States

Editor's pick
Teva press release
10 January 2018
Pharmaceutical industry

Brexit: Fears of disruption to flow of medicines means UK must stay under EU regulation, say government figures

Editor's pick
The Independent
9 January 2018
New & experimental HIV treatments

HIV Drugs in the Pipeline: Expected Approvals for 2018

Editor's pick
Infectious Disease Special Edition
31 December 2017
PrEP policies & guidelines

Pharma giant withdraws challenge to generic HIV anti-retroviral drug

Editor's pick
Irish Times
21 December 2017
Pharmaceutical industry

‘Drugs are too expensive for the NHS – and people are paying with their lives’

Editor's pick
The Guardian
20 December 2017
Pharmaceutical industry

This Company Is About to Flood the US With Cheap HIV Drugs

Editor's pick
Bloomberg
4 December 2017
Hepatitis C treatment

Gilead prices hepatitis C giant Sovaldi in China at one-fifth the US price: report

Editor's pick
FiercePharma
29 November 2017
New & experimental HIV treatments

FDA Approves Juluca, the First Two-Drug HIV Regimen

Editor's pick
Poz
22 November 2017
Pharmaceutical industry

European Medicines Agency will move to Amsterdam

Editor's pick
Science
21 November 2017
Hepatitis A

Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid US outbreaks

Editor's pick
FiercePharma
15 November 2017
PrEP

Danish court invalidates Gilead SPC

Editor's pick
Life Sciences Intellectual Property Review
10 November 2017
PrEP policies & guidelines

Gilead loss of generic HIV drug battle a boost for gay community

Editor's pick
The Irish Times
9 November 2017
Pharmaceutical industry

Why do some HIV drugs cost so much in the US? Pharma, insurers, advocacy groups and consumers weigh in

Editor's pick
BETA blog
3 November 2017
Pharmaceutical industry

GSK and Gilead go head to head as HIV drugs enter new phase

Editor's pick
Reuters
2 November 2017
Access to healthcare

MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug

Editor's pick
Intellectual Property Watch
31 October 2017
Pharmaceutical industry

Gilead HCV drug sales down in 2017 third quarter compared with 2016

Editor's pick
Healio
31 October 2017
Pharmaceutical industry

Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty

Editor's pick
Intellectual Property Watch
26 October 2017